Neurotec Pharma: Clinical Trials

1 trial sponsored by Neurotec Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Neurotec Pharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase IIa Study of NT-KO-003 for Multiple Sclerosis
NT-KO-003 - Relapsing Remitting Multiple Sclerosis
Phase 2CompletedNeurotec Pharma992011-06-012014-03-18

Conditions studied

Multiple Sclerosis, Relapsing-Remitting (1)

Countries

Germany (1)  ·  Spain (1)

Top investigators

Pablo Villoslada, MD PhD (1)